In this op-ed, Maxim Mikheev argues that using biosynthesis to produce cannabinoids could be more environmentally sustainable than commercial scale cultivation.
States across the US are grappling right now with how to securely implement new cannabis patient registries amidst increasing data breaches and patient privacy concerns. Addressing those privacy concerns and HIPAA compliance is only the beginning.
On March 23, 2021, Cannabis Industry Journal is hosting our annual Cannabis Cultivation Virtual Conference. From Noon EST to 5 pm, you’ll get access to nine veterans of the cultivation market.
Green Mill Supercritical recently announced a technology advance that enables winterization onboard the extraction machine during extraction. In this article, Aaron Green interviews Jeff Diehl, Director of Marketing at Green Mill Supercritical, to learn more about the new process.
Aaron Green sits down and interviews Socrates Rosenfeld, CEO of Jane, about their recent strategic partnership with Leafly. The partnership combines two of the largest online tech platforms in the North American cannabis market.
In this series, Aaron Green sits down and interviews a number of integrated cannabis companies and flower brands. In Part 1, Green chats with Sam Ghods, CEO at Connected, to learn more about how he got into cannabis and Connected’s product and branding strategy.
There has been an explosion of interest in THCV recently, as well as a number of other uncommon cannabinoids. There will be big winners and losers in rare cannabinoid markets, but at the end of the day, the highest quality and lowest cost producers will capture most of these markets.
In a press release published last week, the two companies announced they have entered an agreement for Jazz to acquire GW Pharma, the producer of the only FDA-approved CBD medication Epidiolex, for a total of $7.2 billion.
In this article Aaron Green sits down and interviews Mike McDonald, President and CEO at Ammonite, to learn more about their Dablicator™ oil applicator and Ammonite’s hardware platform strategy.
Quicksilver Scientific, a nanoemulsion delivery technology company, announced a partnership with Truss CBD USA, a joint venture between Molson Coors and HEXO Cannabis, to provide their technology in the production of CBD beverages.
